0 citations
Sildenafil citrate, a selective phosphodiesterase type 5 inhibitor: urologic and cardiovascular implications
World Journal of Urology2001Vol. 19(1), pp. 40–45
Citations Over TimeTop 18% of 2001 papers
Related Papers
- → Sildenafil (VIAGRATM), a potent and selective inhibitor of type 5 cGMP phosphodiesterase with utility for the treatment of male erectile dysfunction(1996)604 cited
- → Exploring the Multifaceted Potential of Sildenafil in Medicine(2023)26 cited
- → Phosphodiesterase-5 (PDE5) Inhibitors in the Treatment of Erectile Dysfunction: A Review(2023)7 cited
- → Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertensionA randomized prospective study(2004)20 cited
- Recent advance in research of sildenafil(2002)